PTGS2 and pulmonary fibrosis: Although the cyclooxygenase 2/PGE2 signaling pathway is recognized as a classic anti-inflammatory pathway for inhibiting early inflammation and attenuating the progression of pulmonary fibrosis, its action in mid-to-late-stage fibrosis remains uncertain 53.